The development of protectants to lessen or eliminate chemo and radiotherapy toxicities on normal tissues without lessening the antitumor effects of the cancer therapy has proceeded apace. The ideal protectant would prevent all toxicity, <b>without affecting antitumor activity</b>, and be easy to administer and nontoxic itself. However, most agents developed to date have a much more narrow spectrum of abilities and properties.
